MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS
  • FDA Decision On Tolebrutinib
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Tagged Research summaries

Antihistamine

Antihistamine may stimulate myelin repair

MStranslate
April 13, 2016
Clinical Trials, Remyelination, Research, Treatments
1 Comment
A small, Phase II clinical trial has shown that a common over the counter antihistamine, called clemastine fumarate, has the ability to partially...
stem cell

Stem Cell Culture Media Improves EAE

MStranslate
April 11, 2016
Research, Stem Cells, Treatments
Research Summary: Conditioned Medium from the Stem Cells of Human Exfoliated Deciduous Teeth Ameliorates Experimental Autoimmune...
microbiome

Gut Microbiome Alters Myelination

MStranslate
April 6, 2016
Research, Treatments
Research Summary: Regulation of prefrontal cortex myelination by the microbiota The Background In recent times, there has been an increasing focus...
Rituximab

Rituximab vs Fingolimod in JCV+ Individuals

MStranslate
April 5, 2016
Fingolimod, Natalizumab, Research, Rituximab
Research Summary: Rituximab versus fingolimod after natalizumab in multiple sclerosis patients The background Whilst natalizumab has emerged as...
Plant peptides

Can Plant Peptides Treat Multiple Sclerosis?

MStranslate
March 31, 2016
Research
Research Summary: Oral activity of a nature-derived cyclic peptide for the treatment of multiple sclerosis The background When developing new...
Natalizumab

Natalizumab, B cells and Multiple Sclerosis

MStranslate
March 29, 2016
B Cells, Basic Sciences, Natalizumab, Research, Treatments
Research Summary: Cutting Edge: Integrin a4 is required for regulatory B cell control of experimental autoimmune encephalomyelitis The...

Effects of Exercise on BDNF Protein Levels in MS

MStranslate
March 21, 2016
Lifestyle, Research
Research Summary: Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training The...

MS Risk in Children Born to Vitamin D Deficient Women

MStranslate
March 9, 2016
Lifestyle, Research, Vitamin D
Research Summary: Vitamin D Status During Pregnancy and Risk on Multiple Sclerosis in Women in the Finnish Maternity Cohort The background Many...

Melatonin improves outcomes in mouse model of MS

MStranslate
January 12, 2016
Research, Treatments
Research Summary: Melatonin enhances interleukin-10 expression and suppresses chemotaxis to inhibit inflammation in situ and reduce the severity of...

Female Sex Hormones & Multiple Sclerosis

MStranslate
January 8, 2016
Hormones, Research
It has been known for a while that women are more likely to develop multiple sclerosis than men.  There have been many studies that have indicated...
  1. 8
  2. 9
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14

Recent Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Recent Comments

  • MStranslate on Multiple Sclerosis Research In 2026
  • MStranslate on Multiple Sclerosis Research In 2026
  • K on Multiple Sclerosis Research In 2026
  • Mohammad on Multiple Sclerosis Research In 2026
  • FDA Decision On Tolebrutinib - MStranslate on Multiple Sclerosis in 2025 – Key Developments to Date

Calendar

October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
« Sep    

Archives

Categories

Posts

  • Antiviral Reverses Disability in Mouse Model of MS
  • Assessing & Monitoring Cognition in MS
  • Potential Changes to MS Treatment Access in Australia
  • MS Auckland Webinar: AHSCT as a Treatment for MS
  • MS Auckland Webinar: Remyelination Research in MS

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.